Renal processing of albumin in diabetes and hypertension in rats: Possible role of TGF-β1

American Journal of Nephrology

Volumn 23, Issue 2, 2003, Pages 61-70

  Russo, Leileata M ^a   Osicka, Tanya M ^b,c   Brammar, Gail C ^b,c   Candido, Riccardo ^b,c   Jerums, George ^b,c   Comper, Wayne D ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c AUSTIN HEALTH   (Australia)

Author keywords

Albuminuria; Glomerular permeability; Hypertension; Lysosomal processing; Peptiduria; Protein fragmentation; Streptozotocin; Transforming growth factor 1

Indexed keywords

ALBUMIN; DEXTRAN SULFATE; MESSENGER RNA; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLOMERULUS FILTRATION; HYPERTENSION; KIDNEY FUNCTION; LYSOSOME; MALE; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RADIOIMMUNOASSAY; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SULFATION;

ALBUMINS; ALBUMINURIA; ANIMALS; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR MATRIX PROTEINS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; KIDNEY GLOMERULUS; LYSOSOMES; MALE; NEOPLASM PROTEINS; PERMEABILITY; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037255145     PISSN: 02508095     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068039     Document Type: Article

References (45)

1. Viberti GF: Prognostic significance of albuminuria for the development of nephropathy. J Hypertens 1995;13:S87-S89.
2. Rosa TT, Palatini P: Clinical value of microalbuminuria in hypertension. J Hypertens 2000;18:645-654.
3. Osicka TM, Pratt LM, Comper WD: Glomerular capillary wall permeability to albumin and horseradish peroxidase. Nephrol 1996;2:199-212.
4. Osicka TM, Panagiotopoulos S, Jerums G, Comper WD: Fractional clearance of albumin is influenced by albumin degradation. Clin Sci 1997;93:557-564.
5. Burne MJ, Panagiotopoulos S, Jerums G, Comper WD: Alterations in renal degradation of albumin in early experimental diabetes in the rat: A new factor in the mechanism of albuminuria. Clin Sci 1998;95:67-72.
6. Eppel GA, Osicka TM, Pratt LM, Jablonski P, Howden B, Glasgow EF, Comper WD: The return of glomerular filtered albumin to the rat renal vein. Kidney Int 1999;55:1861-1870.
7. Osicka TM, Comper WD: Protein degradation during renal passage in normal kidneys is inhibited in experimental albuminuria. Clin Sci 1997;93:65-72.
8. Osicka TM, Houlihan CA, Chan JG, Jerums G, Comper WD: Albuminuria in patients with type 1 diabetes is directly linked to changes in the lysosomal-mediated degradation of albumin during renal passage. Diabetes 2000;49:1579-1584.
9. Burne MJ, Osicka TM, Comper WD: Fractional clearance of high molecular weight proteins in conscious rats using a continuous infusion method. Kidney Int 1999;55:261-270.
10. Greive KA, Nikolic-Paterson DJ, Nikolovski J, Pratt LM, Mu W, Atkins RC, Comper WD: Glomerular permselectivity factors are not responsible for the increase in fractional clearance of albumin in rat glomerulonephritis. Am J Pathol 2001;159:1159-1170.
11. Hill C, Flyvbjerg A, Grønbæk H, Petrik J, Hill DJ, Thomas CR, Sheppard MC, Logan A: The renal expression of transforming growth factor-β isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology 2000;141:1196-1208.
12. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 1994;93:536-542.
13. Hamaguchi A, Kim S, Ohta K, Yagi K, Yukimura T, Miura K, Fukuda T, Iwao H: Transforming growth factor-beta 1 expression and phenotypic modulation in the kidney of hypertensive rats. Hypertension 1995;26:199-207.
14. Riser BL, Cortes P, Heilig C, Grondin J, Ladson-Wofford S, Patterson D, Narins RG: Cyclic stretching force selectively upregulates TGF-beta isoforms in cultured rat mesangial cells. Am J Pathol 1996;148:1915-1923.
15. Hirakata M, Kaname S, Chung UG, Joki N, Hori Y, Noda M, Takuwa Y, Okazaki T, Fujita T, Katoh T, Kurokawa K: Tyrosine kinase dependent expression of TGF-beta induced by stretch in mesangial cells. Kidney Int 1997;51:1028-1036.
16. Li Q, Muragaki Y, Hatamura I, Ueno H, Ooshima A: Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and TGF-beta. J Vasc Res 1998;35:93-103.
17. Nakamura T, Miller D, Rouslahti E, Border WA: Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factorβ1. Kidney Int 1992;41:1213-1221.
18. Roberts AB, McCune BK, Sporn MB: TGF-β1: Regulation of extracellular matrix. Kidney Int 1992;41:557-559.
19. Schenk O, Ling H, Sebekova K, Vamvakas S, Heidland A: High-glucose media enhance the responsiveness of tubular cells to growth promoters: Effect on lysosomal cathepsins and protein degradation. Miner Electrolyte Metab 1998;24:254-260.
20. Gilbert RE, Wilkinson-Berka JL, Johnson DW, Cox A, Soulis T, Wu LL, Kelly DJ, Jerums G, Pollock CA, Cooper ME: Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats. Kidney Int 1998;54:1052-1062.
21. Bunag RD: Validation in awake rats of a tail-cuff method for measuring systolic blood pressure. J Appl Physiol 1973;34:279-282.
22. Cefalu WT, Wang ZQ, Bell-Fallow A, Kiger FD, Izlar C: Glycohemoglobin measured by automated affinity HPLC correlates with both short-term and long-term antecedent glycemia. Clin Chem 1994;40:1317-1321.
23. Di Giorgio J: Non protein nitrogenous constituents; in Henry R, Canon D, Winkelman J (eds): Clinical Chemistry: Principles and Techniques. Hagerstown, Harper & Row, 1974, pp 503-563.
24. 14C]protein A, a long lived immunological reagent. J Immunol Methods 1985;81:239-243.
25. Tack BF, Dean J, Eilat D, Lorenz PE, Schecter AN: Tritium labelling of proteins to high specific radioactivity by reductive methylation. J Biol Chem 1980;255:8842-8847.
26. Osicka TM, Kiriazis Z, Pratt LM, Jerums G, Comper WD: Ramipril and aminoguanidine restore renal lysosomal processing in streptozotocin diabetic rats. Diabetologia 2001;44:230-236.
27. 131I-labelled human growth hormone of high specific radioactivity. Biochem J 1963;89:114-123.
28. Bonnet F, Cooper ME, Kawachi H, Allen TJ, Boner G, Cao Z: Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension. Diabetologia 2001;44:874-877.
29. Bohrer MP, Deen WM, Robertson CR, Troy JL, Brenner BM: Influence of molecular configuration on the passage of macromolecules across the glomerular capillary wall. J Gen Physiol 1979;74:583-593.
30. Oliver JD, Anderson S, Troy JL, Brenner BM, Deen WM: Determination of glomerular size selectivity in the normal rat with ficoll. J Am Soc Nephrol 1992;3:214-228.
31. Myers BD, Winetz JA, Chui F, Michaels AS: Mechanisms of proteinuria in diabetic nephopathy: A study of glomerular barrier function. Kidney Int 1982;21:633-641.
32. Deckert T, Kofoed-Enevoldsen A, Vidal P, Nørgaard K, Andreasen HB, Feldt-Rasmussen B: Size and charge selectivity of glomerular filtration in type I (insulin-dependent) diabetic patients with and without albuminuria. Diabetologia 1993;36:244-251.
33. Gall M-A, Rossing P, Kofoed-Enevoldsen A, Nielsen FS, Parving H-H: Glomerular size and charge selectivity in type 2 (non insulin-dependent) diabetic patients with diabetic nephropathy. Diabetologia 1994;37:195-201.
34. Fox JG, Quin JD, Paterson KR, O'Reilly DSTJ, Smith MP, Boulton-Jones JM: Glomerular charge selectivity in type I (insulin-dependent) diabetes mellitus. Diabetic Med 1995;12:387-391.
35. Ruggenenti P, Mosconi L, Sangalli F, Casaraghi F, Gambara V, Remuzzi G, Remuzzi A: Glomerular size-selectivity dysfunction in NIDDM is not ameliorated by ACE inhibition or by calcium channel blockade. Kidney Int 1999;55:984-994.
36. Andersen S, Blouch K, Bialek J, Deckert M, Parving H-H, Myers BD: Glomerular permselectivity in early stages of overt diabetic nephropathy. Kidney Int 2000;58:2129-2137.
37. Brenner BM: Hemodynamically mediated glomerular injury and the progressive nature of kidney disease. Kidney Int 1983;23:647-655.
38. Hostetter TH: Diabetic nephropathy. N Eng J Med 1985;312:642-644.
39. Simons JL, Provoost AP, Anderson S, Rennke HG, Troy JL, Brenner BM: Modulation of glomerular hypertension defines susceptibility to progressive glomerular injury. Kidney Int 1996;46:396-404.
40. Russo LM, Bakris GL, Comper WD: Renal handling of albumin: A critical review of basic concepts and perspective. Am J Kidney Dis 2002;39:899-919.
41. Adler SG, Kang S-W, Feld S, Cha DR, Barba L, Striker L, Striker G, Riser BL, LaPage J, Nast CC: Glomerular mRNAs in human type 1 diabetes: Biochemical evidence for microalbuminuria as a manifestation of diabetic nephropathy. Kidney Int 2001;60:2330-2336.
42. Greive KA, Balazs NDH, Comper WD: Protein fragments in urine have been considerably underestimated by various protein assays. Clin Chem 2001;47:1717-1719.
43. Carraro M, Mancini W, Artero M, Zennaro C, Faccini L, Candido R, Armini L, Calci M, Carretta R, Fabris B: Albumin permeability in isolated glomeruli in incipient experimental diabetes mellitus. Diabetologia 2000;43:235-241.
44. Fabris B, Candido R, Carraro M, Fior F, Artero M, Zennaro C, Cattin MR, Fiorotto A, Bortoletto M, Millevoi C, Bardelli M, Faccini L, Carretta R: Modulation of incipient glomerular lesions in experimental diabetic nephropathy by hypertensive and subhypertensive dosages of an ACE inhibitor. Diabetes 2001;50:2619-2624.
45. Lemley KV, Blouch K Abdullah I, Boothroyd DB, Bennett PH, Myers BD, Nelson RG: Glomerular permselectivity at the onset of nephropathy in type 2 diabetes mellitus. J Am Soc Nephrol 2000;11:2095-2105.